Navigation Links
Swine Flu Vaccine Still in Short Supply
Date:10/23/2009

Goal of 40 million doses by end of October won't be met, CDC says

FRIDAY, Oct. 23 (HealthDay News) -- Production delays continue to hamper distribution of the H1N1 swine flu vaccine, a leading U.S. health official said Friday.

The vaccine is growing more slowly in egg-based cultures than manufacturers had anticipated, resulting in fewer available doses at this time, Dr. Thomas R. Frieden, director of the U.S. Centers for Disease Control and Prevention, said during a news conference.

As of Friday, there were 16.1 million doses on hand nationwide, up from 14.1 on Wednesday, Frieden said. And there will be far fewer than the 40 million doses originally planned for the end of October, he added.

"Vaccine availability is increasing steadily, but far too slowly," Frieden said. "It's frustrating to all of us. We are nowhere near where we thought we would be by now. We are not near where the vaccine manufacturers predicted we would be."

The vaccine that is available comes in both nasal mist and injectable forms. The first doses were only the nasal spray, called FluMist, designed for healthy people 2 to 49 years of age. But now, more than half the doses are injectable, he said.

The H1N1 swine flu continues to produce mild-to-moderate disease in most people, Freiden said. The flu is now widespread in 46 states, he said, adding, "We have already had millions of cases of pandemic influenza in the United States and the numbers continue to increase."

There have been 1,000 laboratory-confirmed deaths due to swine flu since April, according to the CDC.

While children continue to be particularly vulnerable to the disease, Freiden said, "we are seeing it increasingly affect young adults as well as children. We are still not seeing significant numbers of cases among the elderly and that's characteristic of this virus."

That's also a marked difference from run-of-the-mill seasonal flu, which typically poses a much bigger threat to the elderly.

There is encouraging news, Frieden said. The genetic makeup of the H1N1 virus hasn't changed, meaning the swine flu vaccine and the antiviral drug Tamiflu are a good match.

Frieden said the H1N1 flu would probably occur in waves, but "we can't predict how high, how far or long the wave will go, or when the next will come."

"We are now in the second wave of pandemic influenza and whether this will continue through the fall into the winter, whether it will go away and come back in traditional flu season, only time will tell," he said.

Although seasonal flu outbreaks can occur as early as October, most of the time seasonal flu activity peaks in January or later, according to the CDC.

Frieden said that, unlike the H1N1 vaccine, seasonal flu vaccine is plentiful with about 85 million doses distributed so far; more than 60 million people have been vaccinated. "That is way more way sooner than in any prior year," he said.

Until the swine flu vaccine is widely available, experts are urging people to follow oft-stated guidelines, namely avoid crowds, use good respiratory etiquette (i.e. sneeze into your sleeve) and wash your hands frequently.

"Although vaccines are probably the best option, they're not the only option," said Dr. John Treanor, chief of the infectious diseases division at the University of Rochester Medical Center in New York. "We'd love to have the vaccine available now, but for the time being, it looks like we'll have to rely on those non-vaccine interventions."

In other swine flu developments:

  • The World Health Organization reported Friday that nearly 5,000 people are thought to have died from the H1N1 flu since it first emerged last spring in Mexico and the United States before sweeping around the globe.
  • A CDC survey released Thursday found that one in five U.S. children had a flu-like illness earlier this month, and most of the cases were probably swine flu. About 7 percent of adults said they'd had a flu-like illness, the survey found, the Associated Press reported. The results buttress health experts' belief that children and young adults are more susceptible to the swine flu than older adults, who are thought to have some immunity to the disease.
  • U.S. health officials are once again warning consumers about products that are popping up on the Internet that make unsubstantiated claims about preventing or treating the swine flu. These product include: a shampoo said to protect against the H1N1 flu virus, a dietary supplement said to protect infants and young children from contracting the virus, a "new" supplement said to cure H1N1 flu infection within four to eight hours, and several diagnostic tests that have not been approved to detect the H1N1 virus, according to the U.S. Food and Drug Administration.
  • New York state health officials have decided not to require health-care workers across the state to get the swine flu vaccination or risk losing their jobs, since the vaccine is in short supply. Health-care workers had sued the state over the directive, saying it was a violation of their civil rights, according to published reports.

More information

To learn more about the H1N1 swine flu, visit the U.S. Department of Health and Human Services.



SOURCES: John Treanor, M.D., professor, medicine, and chief, infectious diseases division, University of Rochester Medical Center, Rochester, N.Y.; Oct. 23, 2009, news release, U.S. Food and Drug Administration; Oct. 23, 2009, teleconference with Thomas R. Frieden, M.D., M.P.H., director, U.S. Centers for Disease Control and Prevention


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Swine flu monitoring needed for farm workers, study says
2. eFoodSafety Enters Research Agreement with University of Minnesota to Test New Food-Grade Antiviral for Swine Influenza Virus
3. Swine Flu Cases Now Total 7: CDC
4. At Least 16 Dead, Hundreds Ill in Swine Flu Outbreak in Mexico
5. At Least 20 Dead, Hundreds Ill in Swine Flu Outbreak in Mexico
6. International SOS Releases Web Site to Educate Public About Swine Flu Outbreak
7. WHO Warns of Possible Pandemic as Mexico Seeks to Contain Swine Flu
8. U.S. Declares Public Health Emergency in Response to Swine Flu
9. Obama Says Swine Flu Outbreak No Cause for Alarm
10. Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu
11. Swine Flu: Infection Control in Hospitals Will Be Critical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... blend of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , ... have shown to produce NO twice as effectively and sustains NO blood levels ...
(Date:12/5/2016)... Fla (PRWEB) , ... December 05, 2016 , ... ... as Keynote speaker for the 21st Annual International Congress on Hematologic Malignancies®: Focus ... announcement, PER® president, Phil Talamo said, “We are honored to have Amy E. ...
(Date:12/5/2016)... (PRWEB) , ... December 05, ... ... strategic interoperability, today announced that the company will provide alerting technology to ... has been recently awarded $1.7 million in federal funds as the sole ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... geographic lines. The goal of Castlewood Treatment Centers has always been to promote ... to as many people as possible. In that spirit, Castlewood has announced two ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... BSI and ... the United States and Canada for distribution of their natural fruits and beverage ... line is an exciting addition to our Life Sciences product portfolio,” said Steve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report ... Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by ... projected to reach USD 779.8 Million by 2021 from USD 414.6 ... forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 /PRNewswire/ ... titled, "Surgical Sutures Market by Product Type and by Application - Global Opportunity ... for $3,360 million in 2015, and is expected to reach $5,255 million by ... segment dominated the market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: